Optimization and in vivo toxicity evaluation of g4.5 pamam dendrimer-risperidone complexes

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Prieto, Maria Jimena ^a,b   Del Rio Zabala, Nahuel Eduardo ^a,b   Marotta, Cristian Hernan ^a,b   Gutierrez, Hector Carreno ^c   Arevalo, Rosario Arevalo ^c   Chiaramoni, Nadia Silvia ^a,b   Del Valle Alonso, Silvia ^a,b  

^a UNIVERSIDAD NACIONAL DE QUILMES   (Argentina)

^b IMBICE CONICET CCT la Plata   (Argentina)

^c UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

POLYAMIDOAMINE; RISPERIDONE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; COMPLEX FORMATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STABILITY; EMBRYO; HEART RATE; IN VIVO STUDY; MOTONEURON; NONHUMAN; PH; TOXICITY TESTING; ZEBRA FISH;

ANIMALS; ANTIPSYCHOTIC AGENTS; BIOLOGICAL MARKERS; BRAIN; CALBINDIN 2; CELL SURVIVAL; DENDRIMERS; DOPAMINERGIC NEURONS; DRUG CARRIERS; GENE EXPRESSION; HYDROGEN-ION CONCENTRATION; MOTOR NEURONS; RISPERIDONE; SOLVENTS; TYROSINE 3-MONOOXYGENASE; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 84896531734     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090393     Document Type: Article

References (52)

1. Kumar M, Misra A, Babbar AK, Mishra AK, Mishra P, et al. (2008) Intranasal nanoemulsion based brain targeting drug delivery system of risperidone. Int J Pharm 358: 285-291.
2. Courchesne E, Pierce K, Schumann CM, Redcay E, Buckwalter JA, et al. (2007) Mapping early brain development in autism. Neuron 56: 399-413.
3. Marshall CR, Noor A, Vincent JB, Lionel AC, Feuk L, et al. (2008) Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 82: 477-488.
4. Malone RP, Waheed A (2009) The role of antipsychotics in the management of behavioural symptoms in children and adolescents with autism. Drugs 69: 535-548.
5. Mannens G, Meuldermans W, Snoeck E, Heykants J (1994) Plasma protein binding of risperidone and its distribution in blood. Psychopharmacology (Berl) 114: 566-572. (Pubitemid 24152136)
6. Svenson S (2009) Dendrimers as versatile platform in drug delivery applications. Eur J Pharm Biopharm 71: 445-462.
7. Prieto MJ, Bacigalupe D, Pardini O, Amalvy JI, Venturini C, et al. (2006) Nanomolar cationic dendrimeric sulfadiazine as potential antitoxoplasmic agent. International Journal of Pharmaceutics 326: 160-168. (Pubitemid 44754910)
8. Prieto MJ, Schilrreff P, Tesoriero MV, Morilla MJ, Romero EL (2008) Brain and muscle of Wistar rats are the main targets of intravenous dendrimeric sulfadiazine. Int J Pharm 360: 204-212.
9. Prieto MJ, Temprana CF, del Rio Zabala NE, Marotta CH, Alonso Sdel V (2011) Optimization and in vitro toxicity evaluation of G4 PAMAM dendrimerrisperidone complexes. Eur J Med Chem 46: 845-850.
10. Uppuluri S, Keinath SE, Tomalia DA, Dvornic PR (1998) Rheology of dendrimers. I. Newtonian flowbehaviour of medium and highly concentrated solutions of polyamidoamine (PAMAM) dendrimers in ethylenediamide (EDA) solvent. Macromolecules 31: 4498-4510.
11. Uppuluri S, Morrison FA, Dvornic PR (2000) Rheology of dendrimers. 2. Bulk polyamidoamine dendrimers under steady shear, creep and dynamic oscillator. Macromolecules 33: 2551-2560.
12. Bosch P, Corrales T. (2003) Polimeros dendr?ticos: propiedades y aplicaciones. Revista Plasticos Modernos 86: 242-249.
13. Mallamace F, Canetta E., Lombardo D., Mazziglia A., Romeo A., Mons'u Scolaro, L Maino, G. (2002) Scaling properties in the internal structure of dendrimer systems. Physica A 304: 235-243. (Pubitemid 34100233)
14. Canetta E, Maino G. (2004) Molecular dynamic analysis of the structure of dendrimers. Nucl Instrum Meth Phys Res B 213: 71-74.
15. Han M, Chen P, Yang X (2005) Molecular dynamics simulation of PAMAM dendrimer in aqueous solution. Polymer 46: 3481-3488. (Pubitemid 40466083)
16. Cheng Y, Li M, Xu T (2008) Potential of poly(amidoamine) dendrimers as drug carriers of camptothecin based on encapsulation studies. Eur J Med Chem 43: 1791-1795.
17. Cheng Y, Qu H, Ma M, Xu Z, Xu P, et al. (2007) Polyamidoamine (PAMAM) dendrimers as biocompatible carriers of quinolone antimicrobials: An in vitro study. European Journal of Medicinal Chemistry 42: 1032-1038. (Pubitemid 46907335)
18. Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF (1995) Stages of embryonic development of the zebrafish. Dev Dyn 203: 253-310.
19. Hu YL, Qi W, Han F, Shao JZ, Gao JQ (2011) Toxicity evaluation of biodegradable chitosan nanoparticles using a zebrafish embryo model. Int J Nanomedicine 6: 3351-3359.
20. Peterson RT, Macrae CA (2012) Systematic approaches to toxicology in the zebrafish. Annu Rev Pharmacol Toxicol 52: 433-453.
21. Chakraborty C, Hsu CH, Wen ZH, Lin CS, Agoramoorthy G (2009) Zebrafish: a complete animal model for in vivo drug discovery and development. Curr Drug Metab 10: 116-124.
22. McGrath P, Li CQ (2008) Zebrafish: a predictive model for assessing druginduced toxicity. Drug Discov Today 13: 394-401.
23. Sravan Kumar M, Anton Smith A, Alagumani Vasagam G, Kottai Muthu A, Manavalan R (2010) Development of Analytical Method for Risperidone by UV Spectrophotometry. International Journal of Pharma Sciences and Research: 122-126
24. Prieto M, del Rio Zabala N, Marotta C, Bichara D, Simonetta S, et al. (2013) 4.5 Pamam Dendrimer-Risperidone: Biodistribution and Behavioral Changes in In Vivo Model. J Nanomedine Biotherapeutic Discov 4.
25. Connors K (1996) Binding Constants: The Measurement of Molecular Complex Stability. J Inorg Biochem 62: 155-169.
26. Froehlich E, Mandeville JS, Weinert CM, Kreplak L, Taimir-Riahi HA (2011) Bundling an aggregation of DNA by Cationic Dendrimers. Biomacromolecules 12: 511-517.
27. Prieto MJ, Gutierrez HC, Arevalo Arevalo R, Chiaramoni NS, Alonso SdV (2012) Effect of Risperidone and Fluoxetine on the Movement and Neurochemical Changes of Zebrafish. Open Journal of Medicinal Chemistry 2: 129-138.
28. Weruaga E, Velasco A, Brinon JG, Arevalo R, Aijon J, et al. (2000) Distribution of the calcium-binding proteins parvalbumin, calbindin D-28k and calretinin in the retina of two teleosts. J Chem Neuroanat 19: 1-15. (Pubitemid 30406886)
29. Clemente D, Porteros A, Alonso JR, Weruaga E, Aijon J, et al. (2002) Effects of axotomy on the expression of NADPH-diaphorase in the visual pathway of the tench. Brain Res 925: 183-194. (Pubitemid 34133969)
30. Arenzana FJ, Carvan MJ, 3rd, Aijon J, Sanchez-Gonzalez R, Arevalo R, et al. (2006) Teratogenic effects of ethanol exposure on zebrafish visual system development. Neurotoxicol Teratol 28: 342-348. (Pubitemid 43841793)
31. Arenzana FJ, Arevalo R, Sanchez-Gonzalez R, Clemente D, Aijon J, et al. (2006) Tyrosine hydroxylase immunoreactivity in the developing visual pathway of the zebrafish. Anat Embryol (Berl) 211: 323-334. (Pubitemid 44421072)
32. Welch P, Muthukumur M (1998) Tunning the density profile of dendritic polyelectrolytes. Macromolecules 31: 5892-5897. (Pubitemid 128563350)
33. Jansen JF, de Brabander-van den Berg EM, Meijer EW (1994) Encapsulation of Guest Molecules into a Dendritic Box. Science 266: 1226-1229. (Pubitemid 24371278)
34. Ma M, Cheng Y, Xu Z, Xu P, Qu H, et al. (2007) Evaluation of polyamidoamine (PAMAM) dendrimers as drug carriers of anti-bacterial drugs using sulfamethoxazole (SMZ) as a model drug. Eur J Med Chem 42: 93-98. (Pubitemid 46198989)
35. Giansante C, Mazzanti A, Baroncini M, Ceroni P, Venturi M, et al. (2009) Tweezering the Core of Dendrimers: Medium Effect on the Kinetic and Thermodynamic Properties. J Org Chem 74: 7335-7343.
36. Gutierrez-Nava M, Accorsi G, Masson P, Armaroli N, Nierengarten JF (2004) Polarity effects on the photophysics of dendrimers with an oligophenylenevinylene core and peripheral fullerene units. Chemistry 10: 5076-5086.
37. Tajarobi F, El-Sayed M, Rege BD, Polli JE, Ghandehari H (2001) Transport of poly amidoamine dendrimers across Madin-Darby canine kidney cells. Int J Pharm 215: 263-267. (Pubitemid 32206623)
38. Chen CZ, Beck-Tan NC, Dhurjati P, van Dyk TK, LaRossa RA, et al. (2000) Quaternary ammonium functionalized poly(propylene imine) dendrimers as effective antimicrobials: structure-activity studies. Biomacromolecules 1: 473-480.
39. Sweet DM, Kolhatkar RB, Ray A, Swaan P, Ghandehari H (2009) Transepithelial transport of PEGylated anionic poly(amidoamine) dendrimers: implications for oral drug delivery. J Control Release 138: 78-85.
40. Choi JS, Nam K, Park JY, Kim JB, Lee JK, et al. (2004) Enhanced transfection efficiency of PAMAM dendrimer by surface modification with L-arginine. J Control Release 99: 445-456. (Pubitemid 39296913)
41. Braun CS, Vetro JA, Tomalia DA, Koe GS, Koe JG, et al. (2005) Structure/ function relationships of polyamidoamine/DNA dendrimers as gene delivery vehicles. J Pharm Sci 94: 423-436. (Pubitemid 40293337)
42. Xiangyang S, Wang S, Swanson SD, Ge S, Cao Z, et al. (2008) Dendrimer-Functionalized Shell-crosslinked Iron Oxide Nanoparticles for In-Vivo Magnetic Resonance Imaging of Tumors. Adv Mater 20: 1671-1678.
43. Airhart MJ, Lee DH, Wilson TD, Miller BE, Miller MN, et al. (2007) Movement disorders and neurochemical changes in zebrafish larvae after bath exposure to fluoxetine (PROZAC). Neurotoxicol Teratol 29: 652-664. (Pubitemid 350101084)
44. Wong J, Brugger A, Khare A, Chaubal M, Papadopoulos P, et al. (2008) Suspensions for intravenous (IV) injection: a review of development, preclinical and clinical aspects. Adv Drug Deliv Rev 60: 939-954.
45. Seibt KJ, Oliveira Rda L, Rico EP, Dias RD, Bogo MR, et al. (2009) Antipsychotic drugs inhibit nucleotide hydrolysis in zebrafish (Danio rerio) brain membranes. Toxicol In Vitro 23: 78-82.
46. Tessier C, Nuss P, Staneva G, Wolf C (2008) Modification of membrane heterogeneity by antipsychotic drugs: an X-ray diffraction comparative study. J Colloid Interface Sci 320: 469-475.
47. Chiaramoni NS, Speroni L, Taira MC, Alonso Sdel V (2007) Liposome/DNA systems: correlation between association, hydrophobicity and cell viability. Biotechnol Lett 29: 1637-1644. (Pubitemid 47493542)
48. Alonso-Romanowski S, Chiaramoni NS, Lioy VS, Gargini RA, Viera LI, et al. (2003) Characterization of diacetylenic liposomes as carriers for oral vaccines. Chem Phys Lipids 122: 191-203. (Pubitemid 36207526)
49. Taira MC, Chiaramoni NS, Pecuch KM, Alonso-Romanowski S (2004) Stability of liposomal formulations in physiological conditions for oral drug delivery. Drug Deliv 11: 123-128. (Pubitemid 38437081)
50. D'Emanuele A, Attwood D (2005) Dendrimer-drug interactions. Adv Drug Deliv Rev 57: 2147-2162. (Pubitemid 41760432)
51. Fischer D, Li Y, Ahlemeyer B, Krieglstein J, Kissel T (2003) In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials 24: 1121-1131. (Pubitemid 36069121)
52. Mecke A, Uppuluri S, Sassanella TM, Lee DK, Ramamoorthy A, et al. (2004) Direct observation of lipid bilayer disruption by poly(amidoamine) dendrimers. Chem Phys Lipids 132: 3-14. (Pubitemid 39458316)